SMTL ID : 6e72.1

Structure of Human Transthyretin Val30Met Mutant in Complex with Tafamidis

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.45 Å

Oligo State

homo-tetramer

Ligands

4 x 3MI: 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid(Non-covalent)

3MI.1: 15 residues within 4Å: Chain A: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain C: L.8, T.97, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.3 4 PLIP interactions: 1 interactions with chain C, 3 interactions with chain A Hydrophobic interactions: C:T.110, A:K.6, A:L.101 Salt bridges: A:K.6 3MI.2: 15 residues within 4Å: Chain B: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Chain D: L.8, T.97, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.4 5 PLIP interactions: 3 interactions with chain B, 2 interactions with chain D Hydrophobic interactions: B:K.6, B:L.101, D:A.99, D:T.110 Salt bridges: B:K.6 3MI.3: 15 residues within 4Å: Chain A: L.8, T.97, A.99, L.101, S.108, T.109, T.110 Chain C: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.1 4 PLIP interactions: 3 interactions with chain C, 1 interactions with chain A Hydrophobic interactions: C:K.6, C:L.101, A:T.110 Salt bridges: C:K.6 3MI.4: 15 residues within 4Å: Chain B: L.8, T.97, A.99, L.101, S.108, T.109, T.110 Chain D: K.6, L.8, A.99, L.101, S.108, T.109, T.110 Ligands: 3MI.2 5 PLIP interactions: 2 interactions with chain B, 3 interactions with chain D Hydrophobic interactions: B:A.99, B:T.110, D:K.6, D:L.101 Salt bridges: D:K.6

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Saelices, L. et al., Structural Variants of Transthyretin. To Be Published

Release Date

2019-07-31

Peptides

Transthyretin: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Transthyretin

Related Entries With Identical Sequence